Ameriprise Financial, Inc. (NYSE: AMP) — A 50%-ROE Wealth Manager Wearing the Insurer’s Multiple It’s Outgrowing

Independent equity research. Report date: 2026-06-21. Price reference: $467.43 (2026-06-18 close). All figures USD unless noted.

⚡ Claude’s Take

This block is the author’s own independent opinion and general information only. It is not investment advice. The analysis that follows takes no position and carries no price target — that discipline is reserved to everything below this block.

Verdict: HOLD / accumulate-on-weakness. Not-a-short. Medium conviction. Directional value zone: fair-to-cheap at ~$467 (~11.9x FY25 adjusted operating EPS of $39.29, ~10.6x FY26E ~$44); I would accumulate into the high-teens-multiple zone of roughly $400–435 (≈10x forward), where the rate-cycle bear is fully discounted and the re-rating optionality comes free.

Ameriprise is the rare large financial where the quality and the price point the same direction and the only real debate is about cyclical timing. This is a ~53% adjusted-operating-ROE, capital-light wealth manager that has compounded adjusted operating EPS at ~17–20% for five years, shrunk its share count ~22%, and returned ~88% of earnings — yet trades at ~11.6x earnings, the second-lowest multiple in its cohort (above only the distressed active manager T. Rowe), while wealth-management pure-plays it resembles in earnings mix command 14–27x (RJF ~13x, MS ~15x, SCHW ~19x, LPL ~27x). The market prices the whole company at a slow, rate-levered diversified-financial/insurer multiple because of two real-but-minority drags — a ~16%-of-earnings runoff annuity tail (RPS) and a ~19% melting active manager (Columbia Threadneedle) — and because a chunk of the recent earnings beat is high-rate cash-sweep NII (down 11% in 2025 and still rolling over). My sum-of-the-parts lands near ~$597, ~28% above spot, and even a flat-EPS, no-re-rate bear scenario (~$380–495) brackets today’s price. The framing is abandoned-quality / value re-rate, not momentum and not a falling knife: the stock is ~17% off its January-2025 high, has lagged the market for twelve months (rs_12m −6.5%), carries pure ~1.05 market beta with negative growth-factor loading — a cheap, ignored, high-ROE name the tape has stopped watching.

Why only a HOLD and not a table-pound? Because the bear’s single best point is true: today’s record ROE and ~$39–44 EPS sit on both a high-rate NII vintage and a bull-market AUM peak, and a simultaneous Fed-cut-plus-equity-drawdown would hit fees and spread together — the earnings are at a cyclical high, not a trough, so paying up here forfeits the margin of safety. Insiders agree enough to keep selling (zero open-market buys in five years). I want the discount, not just the quality. Conviction flip bullish: two-to-three more quarters proving AWM advice-fee growth out-earns NII compression through the cut cycle (it did in 2025: +14% fees vs −11% NII) plus any sign the market begins re-rating toward wealth peers. Flip bearish: NII compresses faster than fees and AWM organic net flows decelerate to peer-lagging levels — confirming the market’s “it really is a rate-levered diversified financial” classification is correct, not a mistake. Tag: the wealth compounder hiding in an insurer’s costume.

📈 Stock Price Action — Five-Year Event Map

Over the trailing ~60 months AMP round-tripped from a five-year low of ~$210.6 (14-Jul-2022, the mid-2022 bear-market trough) to an all-time high of ~$564.1 (29-Jan-2025), and now sits at $467.43 (18-Jun-2026) — roughly −17% off the ATH and mid-range of a 52-week band of ~$428.8 (06-Apr-2026) to ~$542 (Feb-2026). Market cap ~$42.4B on ~90.8M shares. Beta has fallen from ~1.69 (2021–22) to ~1.05 today as the rate-windfall earnings stabilized the business. The arc is overwhelmingly a rate-and-market story bolted onto a relentless buyback.

Cycle narrative. (1–2) AMP traded as a high-beta cyclical into the 2022 bear, bottoming ~$210. (3) Once Fed hikes turned client sweep balances into an NII windfall, the stock re-rated as a rate beneficiary, +55% in six months. (4) The 2023 regional-bank crisis briefly spooked deposit/sweep investors. (5) The 18-month run to the ~$564 ATH stacked the high-rate NII plateau, an equity melt-up lifting fee AUM, and ~3–4%/yr share-count reduction — EPS compounding from three directions at once. (6) The top coincided with the market deciding rates (and therefore sweep NII) had peaked, amplified by the April-2025 drawdown — the “peak earnings” de-rate that still anchors the bear case. (7) Resilient FY25/Q1-26 prints drove a recovery toward ~$542. (8) The latest pullback to ~$467 is renewed NII-compression anxiety as cuts firm. The stock now sits mid-range, ~17% off its high, de-rated to ~11–12x on a “peak rate earnings” narrative — the price context the valuation section below interrogates. (Price moves = Fact from the AZI five-year daily CSV; attributed causes = Interpretation.)

1. Executive Summary

Ameriprise Financial is a Minneapolis-based, wealth-management-led diversified financial firm, spun from American Express in 2005, that has spent two decades deliberately converting itself from an insurance/annuity company into a fee-based advice business. In FY2025 it earned $3,563M of GAAP net income ($36.28 diluted) / $3,858M adjusted operating ($39.29 diluted) on $18,480M of net revenue, at an adjusted operating return on equity excluding AOCI of 53.2% — among the highest of any large financial in the United States.

The franchise is now built on three legs of very different quality. Advice & Wealth Management (AWM) is the crown jewel — ~65% of segment pretax operating earnings, a $664B advisory-wrap-fee machine with >10,000 advisors at record $1.2M productivity, growing advice fees +14% in 2025. Columbia Threadneedle (Asset Management) is ~19% of earnings and a structurally challenged active manager bleeding net outflows every year (−$31.7B in 2025). Retirement & Protection Solutions (RPS) is ~16% — a de-risked, captive RiverSource annuity/insurance manufacturer run as a cash-flow spigot. The moat lives in AWM: a genuine Greenwald customer-captivity-plus-scale advantage (sticky multi-product client relationships, rising productivity, returns far above cost of capital), but one that requires continuous reinvestment to retain mobile advisors in an inflating LPL/RJF recruiting war.

The central investment tension is a classification mispricing. AMP trades at ~11.6x trailing adjusted operating EPS — the second-lowest multiple in its peer cohort — yet earns the highest operating ROE in that cohort and resembles wealth pure-plays (LPL ~27x, SCHW ~19x, MS ~15x, RJF ~13x) far more than the insurers/active managers whose multiple it carries. The market is applying a blanket rate-levered-diversified-financial discount to a company that is ~65% recurring advice fees. A sum-of-the-parts (~$597) and even a flat-EPS bear scenario (~$380–495, which brackets today’s price) both suggest the discount is excessive.

The bear case is not frivolous. Today’s record earnings sit on a high-rate cash-sweep NII vintage (already −11% in 2025 and compressing further on Fed cuts) and a bull-market AUM peak; ~half of the five-year EPS growth is buyback mechanics; Columbia Threadneedle is in secular decline; and the firm carries equity-market beta (~$510M of pretax fee income at risk per 10% market drawdown). The balance sheet is a fortress (RiverSource RBC 523%, negative net debt, modest SBC), capital allocation is genuinely shareholder-aligned (comp tied to ROE-ex-AOCI and per-share metrics; 15 straight years of ~85–90% capital return), and the chief governance flaw is succession: James Cracchiolo has been Chairman+CEO since the 2005 spinoff with no named successor. This memo takes no position and sets no price target; it lays out the embedded expectations, the segment economics, and the falsification tests for each side.

2. Business Overview

What AMP is. Ameriprise Financial provides financial planning, advice, brokerage, banking, asset management, annuities and insurance to ~3.5M+ retail clients and institutional clients, primarily in the US with a meaningful EMEA/Asia asset-management presence. It is organized into four segments: Advice & Wealth Management, Asset Management, Retirement & Protection Solutions, and Corporate & Other. The firm is a savings-and-loan holding company (and financial holding company) regulated by the Federal Reserve, owns a federal savings bank (Ameriprise Bank, FSB) and the Ameriprise Certificate Company, and manufactures annuities/insurance through RiverSource Life. (Fact — FY2025 10-K, Item 1.)

Consolidated revenue mix (FY2025, GAAP). Total net revenues $18,480M (+7%). The build: Management & financial advice fees $11,109M (≈60% of total revenue, +10%); Distribution fees $2,117M (+3%); Net investment income $3,570M (−2%); Premiums/policy/contract charges $1,587M (+2%); Other $528M. (Fact — 10-K MD&A.) The single most important structural fact: ~60% of revenue is asset-/advice-based management fees that scale with AUM — recurring, market- and flow-sensitive — with net investment income (~19% of revenue) the rate-sensitive leg. This is a fee-gathering machine wrapped around a shrinking insurance/spread book.

Segment pretax adjusted operating earnings (FY2025). AWM $3,411M (+6%), Asset Management $1,016M (+10%), RPS $846M (+17%); Corporate & Other a loss. The three operating segments sum to $5,273M, mixing AWM 64.7% / AM 19.3% / RPS 16.0%. (Fact — 10-K segment tables.) AWM is now roughly two-thirds of operating earnings and the sole growth engine — the visible result of AMP’s two-decade shift away from its annuity-company roots.

How AWM actually makes money (the crown jewel, quantified). AWM total net revenues $11,741M (+9%); pretax adjusted operating margin 29.1% (down 90bps from 30.0%). Three income streams:

• (1) Advisory wrap fees — the core. Ending advisory wrap assets $664.4B; total wrap $670.4B (+17%) on net inflows $30.9B plus $65.6B market appreciation; average advisory wrap +15% to $606.2B. This drives the $7,371M management/advice-fee line (+14%). (Fact — 10-K wrap table.)
• (2) Distribution fees $2,520M (+3%) — point-of-sale, asset-based 12b-1, brokerage transactional, and third-party sweep-placement fees. Note +$119M from transactional activity but −$52M brokerage cash revenue — the cash-cow erosion is already visible at the margin.
• (3) Net investment income / cash spread $1,956M (−11%) — the rate-sensitive piece, earned on Ameriprise Bank and Certificate Company assets. Banking/deposit interest expense ($431M, −35%) is netted here.

So AWM revenue is roughly 63% recurring advice/management fees + 21% distribution + 16% NII — the spread leg is the swing factor on rates but is a minority of AWM revenue, and (per management) a smaller share of earnings than at cash-dependent peers like Schwab, where net interest is ~49% of total revenue.

The cash / bank engine. Total AWM client cash $87.0B: Ameriprise Bank deposits $23.7B (+6%), Certificate balances $8.2B (−$3.0B, eight straight quarters of outflow), broker-dealer on-balance-sheet $1.9B, off-balance-sheet sweep $5.1B, and $48.1B in third-party cash products (MMFs/brokered CDs). Cash-sweep balances ~$29.4B (Q1-26). The economics: AMP sweeps client cash into its own bank, paying clients ~0.28% on bank deposits while investing the $20.5B AFS portfolio at a ~4.6% yield (≈4yr duration, mostly AA+ structured, only 9% floating-rate after deliberate term-out). (Fact — 10-K client-cash table + Q1-26 call.) This is the same spread economics as Schwab/Morgan Stanley but far smaller as a share of earnings, and deliberately stabilized.

The advisor force. >10,000 financial advisors across four affiliation channels: Ameriprise Franchise Group (independent franchisees — the largest), Ameriprise Advisor Group (W-2 employees), Ameriprise Personal Wealth Group (centralized virtual advice / succession vehicle), and Ameriprise Financial Institutions Group (AFIG — advisors based in third-party banks/credit unions). Adjusted operating net revenue per advisor reached $1,122K in FY2025 (+8%) and a record $1.2M run-rate in Q1-26 (+10%). Client satisfaction 4.9/5; J.D. Power 2026 ranked 3rd of 23. In Q1-26 AMP signed Huntington Bank to AFIG (~260 advisors, ~$28B, onboarding Q4-26) while losing Comerica (early-terminated after Fifth Third’s acquisition; $25M one-time make-whole; ~$18B leaving through Q3-26). (Fact — Q1-26 call.)

Asset Management (Columbia Threadneedle). Total managed assets $678.1B; segment net revenues $3,621M (+3%); pretax $1,016M (+10%) on equity appreciation, +$55M performance fees, and cost cuts; margin reached 44% in Q1-26 (above the 35–39% target). The structural problem: net outflows of −$31.7B in FY2025 (Global Retail −$25.3B, Global Institutional −$22.1B), worse than −$20.4B in 2024 — only market beta keeps total AUM rising. Mitigants (ETF platform >$10B, top-10 SMA provider, alternatives) are right-direction but sub-scale.

Retirement & Protection Solutions (RiverSource). Pretax $846M (+17%; ~$800M/yr run-rate); VA account balances $91.3B; living-benefit rider mix down to 46% from 50% (no new living benefits sold since mid-2022). RiverSource is the exclusive new-annuity manufacturer to AMP advisors; legacy blocks are being reinsured (LTC ~50% ceded to Genworth; fixed annuities ~89% ceded). It is a de-risking, cash-generative captive manufacturer, not a growth story.

Verdict. AMP is a wealth-management-led franchise (~65% of earnings, ~60% of revenue recurring advice/management fees) with two supporting legs — a melting active manager and a de-risked annuity book — that the market weights more heavily than their earnings contribution warrants. The business has been deliberately and successfully repositioned toward the highest-quality fee segment.

3. Industry Dynamics

AMP straddles three industries of sharply different structural quality, and its earnings are concentrated in the best one.

US wealth management / advice (~65% of earnings) — structurally GOOD. Secular demand is rising on both sides of the demographic ledger: baby-boomer retirement decumulation and younger-generation wealth accumulation. The multi-decade migration from commission/transactional to fee-based advisory continues to expand the recurring-revenue profit pool. The economics favor scale players with a fixed advice/tech platform and high client switching costs. AMP targets the mass-affluent ($500K–$5M investable) plus HNW. (Fact — 10-K Item 1; Interpretation.)

The one live negative is an inflating advisor-recruiting war. LPL Financial runs ~32,000 advisors (net +601 in 2025, the biggest gainer, plus the ~2,900-advisor Commonwealth acquisition at ~77.5% retention); Raymond James reached record headcount (net +313, winning ~33% of departing Commonwealth advisors); Morgan Stanley Wealth manages $9.3T client assets. Edward Jones, Stifel, Wells Fargo Advisors and Schwab/RIA-custody also compete. AMP itself flagged that current recruiting-deal economics (“long cash paybacks, marginal P&L benefit”) exceed its risk tolerance — disciplined, but it cedes net-headcount growth. (Fact — InvestmentNews/Financial Planning 2025; Morgan Stanley disclosures.) So the industry is excellent for asset gatherers, but the cost of acquiring the asset-gathering talent is rising — a margin/flow headwind.

Active asset management (~19% of earnings) — structurally BAD. Active mutual funds saw ~$640B of outflows in 2025 (~$4T cumulative over the decade); passively-managed assets (~$19.1T) now exceed active (~$16.2T); fees are compressing faster than in prior cycles. Survivors must reach BlackRock-scale, pivot hard to active ETFs/SMAs/private markets, or be acquired. (Fact — Morningstar/McKinsey 2025.) Columbia Threadneedle is squarely caught: net outflows every year, sub-scale globally, pivoting late. This is a melting (slowly) ice cube whose value to AMP is mostly captive manufacturing + cash harvesting, not a standalone franchise.

Insurance/annuity (~16% of earnings) — mature, capital-intensive, but a de-risked slice. AMP runs a shrinking, reinsured, cash-generative book rather than chasing new long-tail liabilities. Industry pressures (rates, capital intensity, longevity assumptions) apply, but AMP’s deliberate de-risking neutralizes most of the tail.

The cross-cutting cash-sweep / “AI cash cow” debate. The 2025–26 industry narrative (“AI Could Kill the Brokerage Industry’s Cash Cow”) holds that AI tools, fee transparency, and client cash-sorting will erode the spread brokers earn by paying low rates on idle sweep cash. Schwab (net interest ~49% of revenue) and Morgan Stanley (E*TRADE sweep litigation; ~$400B+ sweep deposits) are the most exposed. AMP is meaningfully less exposed: cash/NII is ~16% of AWM revenue and a smaller share of total earnings; the bank book is termed-out and stable; the average client account cash balance is only ~$6,000 (transactional, not investable cash being mined); management frames cash as “stable,” not “harvested.” (Fact — Q1-26 call; Schwab and Morgan Stanley public disclosures.) This is a genuine structural advantage of AMP’s advice-fee-led mix — though declining rates still compress the spread, and the very low 0.28% deposit rate is the part vulnerable to regulatory/transparency pressure.

Verdict. Mixed-to-good, bifurcated by segment, but favorable on a weighted basis because AMP’s earnings are concentrated in the structurally good wealth/advice segment. The active-AM industry is structurally bad (a multiple cap on ~19% of earnings); the cash-cow/NII risk that haunts the discount brokers is materially less acute for AMP. The principal industry headwind is the rising cost of advisor talent.

4. Competitive Position

The moat lives in AWM, and it is real. In Greenwald’s taxonomy, AWM possesses a customer-captivity (switching-cost/habit) advantage layered with modest economies of scale on the advice/tech platform — the most durable combination type. It is not a network effect and not a low-cost-production moat. The captivity shows up in financial outcomes, which is the only test that matters:

• Rising productivity: adjusted operating net revenue per advisor +8–10%/yr to $1.2M — clients consolidate assets with their advisor over time (wrap +17%, net inflows $30.9B even in a cautious year).
• Sticky multi-product relationships: planning fees, wrap, banking (HELOCs/checking/pledged lending), and annuities/insurance bundled around one advisor relationship raise the cost of leaving.
• High satisfaction/retention: 4.9/5 client satisfaction, J.D. Power 3rd of 23 — the advisor is the switching-cost asset, and AMP’s integrated tech/CRM/advice platform retains advisors and their books.
• Returns far above cost of capital: even on the conservative ~13–14% reported GAAP ROE, returns clear the hurdle comfortably; on the operating-economics basis (adjusted operating ROE-ex-AOCI 53.2%) AWM is an extraordinarily high-return, capital-light fee business.

Pressure test — what limits the moat. AWM is partly a distribution business, not a pure franchise. The advisor — not the Ameriprise brand — owns much of the client relationship, and advisors are mobile: LPL and RJF recruit them aggressively, and AMP’s own Q1-26 flows were dented by departures. Captive manufacturing (Columbia funds + RiverSource annuities pushed through AMP advisors) adds economics but also conflict-of-interest/fiduciary risk. The captivity is real at both the client-advisor and the platform/scale level, but the firm must keep paying (comp, tech) to retain advisors — this is a moat that requires continuous reinvestment, not a toll bridge.

Columbia Threadneedle — no durable moat. A melting active manager: persistent net outflows, fee compression, sub-scale globally. Decent fund performance (>70% of funds above peer median on 1/3/5yr) and a late ETF/SMA/alts pivot are mitigants, not a moat. It has neither scale (vs BlackRock/Vanguard) nor genuine captivity (institutional money repositions to passive at will).

RPS/RiverSource — narrow captive-channel advantage. Exclusive new-annuity manufacturing to AMP’s own advisors gives a guaranteed, low-acquisition-cost distribution channel — a real edge versus insurers fighting for shelf space — but the underlying annuity/life business is a commoditizing, capital-intensive industry. The moat is the channel, not the product.

Head-to-head. Versus LPL (~32,000 advisors, pure custodial/platform, recruiting machine): AMP has far fewer advisors but higher productivity and a more integrated, branded, higher-margin advice model plus captive manufacturing and a bank — LPL wins the headcount war, AMP wins the per-advisor-economics war. Versus Raymond James (the closest analog — branded, advice-led, multi-channel, a bank/NII leg): AMP’s productivity and capital-return discipline differentiate. Versus Morgan Stanley Wealth ($9.3T assets, HNW/UHNW + workplace funnel + investment bank): the closest moat analog but at far larger scale and a richer client tier — AMP plays mass-affluent, MS plays up-market. Versus Schwab (scale/cost moat, RIA custody + discount brokerage, NII ~49% of revenue): a different, far more cash-cow-dependent model — AMP’s advice-led, lower-cash-dependence mix is a relative defensive advantage in the AI-cash-cow debate.

Verdict. A durable advantage in the segment that matters (AWM, ~65% of earnings) — a real customer-captivity-plus-scale moat evidenced by rising productivity, sticky relationships, high retention, and through-cycle returns well above cost of capital. But it is maintenance-intensive (mobile advisors in an inflating recruiting war), partly distribution rather than pure franchise, and diluted by a no-moat Columbia Threadneedle and a narrow-captive RPS. Superior, more durable, and less cash-cyclical than the discount brokers — but not an unassailable toll bridge.

5. Growth History and Forward Opportunities

Historical decomposition (5yr). Total net revenues grew $11.9B (2020) → $18.48B (2025), a ~9.2% CAGR — matching management’s stated “9% compounded annual revenue growth.” GAAP net income $1.53B → $3.56B. Adjusted operating EPS reached $39.29 in FY2025, a ~20% five-year CAGR (“20% compounded annual EPS growth,” per the CFO). (Fact — 10-K MD&A; Q1-26 call.) The ~11-point wedge between ~9% revenue growth and ~20% EPS growth is the buyback engine: diluted average shares fell 123.8M (2020) → 98.2M (2025), ~21%. Roughly half of per-share earnings growth is buyback-driven, half operating — AMP is a capital-return compounder as much as an organic-growth story.

Organic vs acquired. The only material acquisition in the window is BMO’s EMEA asset-management business (closed Nov-2021, ~$845M, +~$124B AUM to Columbia Threadneedle). Everything else is organic plus bolt-on/reinsurance — management self-describes the model as “organic growth, built not bought.” (Fact — 10-K; Q1-26 call.) Tellingly, the one acquisition reinforced the weakest segment (active AM, now in outflows). AWM growth is essentially 100% organic.

The AWM growth math (the engine). Management & financial advice fees $6,492M → $7,371M, +14%, on average wrap assets +15%. Net flows $30.9B on a ~$570B starting wrap base ≈ ~5.4% organic wrap growth; the rest of the +17% wrap jump is market beta. Crucially, the advice-fee flywheel (+$879M) outran the NII decline (−$239M) by ~3.7:1 in 2025 — the central proof point that fee growth offsets cash-spread roll-off. Productivity reached a record $1.2M/advisor (+10%). (Fact — 10-K AWM table; Q1-26 call.)

The NII headwind. AWM NII fell 11% (−$239M) in 2025; the average rate paid on bank deposits dropped to 0.28% (from 0.44%); certificate balances fell $3.0B (eight straight quarters). This is the principal cyclical headwind — the 2022–24 high-rate vintage inflated AWM earnings via the cash spread, and Fed cuts now compress it. Mitigants AMP has deliberately built: a termed-out bank book (9% floating, ~4yr duration locking ~4.6–5.0% yields), a full bank product suite (HELOCs/checking/pledged lending) growing NII via volume not just spread, and ~$48B of third-party MMF cash management frames as redeployment optionality into fee-earning wrap as rates fall.

The AM drag. Total AUM net outflows −$31.7B in FY2025 (worse than −$20.4B in 2024), improving to −$5.9B in Q1-26 on +26% gross retail sales. “Growth” here is margin/efficiency-driven (44% Q1 margin on cost-out and back-office outsourcing), not flow-driven — a managed decline, not a growth contributor.

Forward drivers (ranked). (1) AWM wrap/advice-fee growth — highest-quality, durable; plus the $48B third-party cash redeployment optionality. (2) AFIG bank/credit-union channel — Huntington signed (~260 advisors/$28B, 10-yr, “IRRs very good”); the thesis that banks/credit unions increasingly want wealth management but won’t make the platform investment, so they outsource to AMP — a structural pipeline, albeit lumpy and contestable (partners can be acquired, à la Comerica). (3) Advisor productivity via AI/tech — embedded AI “takes away hours of work per week,” framed as capacity not headcount cuts. (4) Signature Wealth UMA — a fast-ramping mid-2025 wrap launch bringing new money and a fee-rate uplift. (5) Bank product suite — pledged lending/HELOC/checking growing NII via volume. (6) Buyback-driven EPS — ~5%/yr share shrink at ~11–13x continues mechanically under the $4.5B authorization.

Forward headwinds. AM secular outflows; NII/cash-spread compression on cuts; the inflating advisor-recruiting war suppressing net headcount; and a 2026 flow air-pocket between Comerica outflows (Q2–Q3) and Huntington inflows (Q4).

Verdict. High-quality engine, medium-durability growth rate. The durable core (AWM advice-fee growth +14%, rising productivity) is genuinely high quality — recurring, fee-on-AUM, capital-light, organic. But the headline ~20% EPS CAGR is flattered on three counts that will not all repeat: ~half is buyback mechanics; the 2022–24 NII vintage is rolling over; and market appreciation, not flows, supplied the bulk of AUM growth. Net organic flow growth is ~5% in AWM and negative in AM. Forward growth is real but lower and lumpier than the headline implies — normalizing toward low-double-digit.

6. Financial Quality

The headline correction: the real ROE, and why equity is tiny. FY2025 GAAP net income $3,563M sits on year-end common equity of only $6,549M (common $3M + APIC $10,377M + retained earnings $27,662M − treasury stock $30,601M + AOCI −$1,305M). Real GAAP ROE on year-end equity ≈ 54%; AMP’s own 10-K reports return on equity excluding AOCI of 49.1% and adjusted operating ROE-ex-AOCI of 53.2% (target: >30%; “best-in-class,” up 60bps, per the proxy). (Fact — 10-K consolidated balance sheet + MD&A ROE reconciliation.)

A critical data note: ROIC.ai’s reported “13.6% ROE” and any “~1.6x P/B on a ~$303 book value” are garbage for AMP — they divide earnings by an inflated equity base that wrongly sweeps in separate-account/policyholder balances (total assets are $190.9B but ~$140B+ is separate-account money that is not common equity). Ignore them. Real common equity is ~$6.5B; real GAAP ROE ~54%. (Interpretation, reconciled to the filing.)

Equity is small for two structural reasons. (1) Relentless capital return: treasury stock has built to $30,601M (2025) from $18,879M (2020); of 338.1M shares issued, only 91.3M are outstanding (~247M bought back and parked in treasury), so retained earnings ($27.7B) are almost entirely offset by treasury stock ($30.6B). (2) AOCI drag: AOCI swung from +$629M (2020) to −$2,546M at the 2022 rate-hike trough, recovering to −$1,305M (2025) as the AFS bond book’s unrealized losses bleed back. AMP deliberately runs a thin-equity, high-ROE model funded by insurance/bank float and recurring fee cash flow — the thin equity is a choice, and the engine of the per-share compounding.

GAAP vs adjusted operating — a small, legitimate gap. FY2025 GAAP NI $3,563M ($36.28) → adjustments of just −$295M (almost entirely a −$366M non-cash market-impact mark on the runoff variable-annuity/IUL book, partly tax-offset) → adjusted operating earnings $3,858M ($39.29) on 98.2M diluted shares. The 2023 GAAP dip ($25.37/sh; adj op $28.86) was driven by VA hedge/market marks (−$191M), the SEC recordkeeping accrual, severance, and $62M integration — precisely the items the adjusted measure backs out. (Fact — 10-K reconciliation.) This is the rare case where the non-GAAP measure is the more economically representative number, not a flattering one. Cross-check: operating cash flow / net income ran 2.34x in 2025 (1.94x in 2024) — cash generation massively exceeds GAAP NI (insurance/working-capital float), confirming the earnings are real cash, not accrual fiction.

Rate/NII share of earnings (the cyclical kicker, now reversing). AWM net investment income $1,956M (2025) vs $2,195M (2024), −11%; net AWM spread (NII − deposit interest) ≈ $1,525M, roughly flat YoY because deposit costs fell too. That is ~$1.5B of net spread inside the $3.4B AWM segment — a material slug of rate-driven income that ballooned 2022–24 and is now compressing. The bull case requires advice-fee growth (+14%) to keep outrunning NII decay; in 2025 it did (AWM still +6% with NII down). This is the single biggest earnings-quality swing factor: the record ROE is partly a high-rate vintage, partially offsettable by the asset-gathering flywheel.

Does it improve with scale? Yes — in AWM (asset-light, fee-on-AUM, 30%+ incremental margins) and RPS (spread/fee on a de-risked book). Asset Management is the structurally weaker, flow-challenged unit that masks franchise quality. Consolidated adjusted operating margin 26.9% (+40bps).

Balance sheet / liquidity / capital. Recourse corporate (senior-note) debt is ~$3.1–3.3B (the “$5.9B” some screens show includes non-recourse/consolidated-entity debt); net debt is negative at the consolidated level (more cash/investments than debt). RiverSource Life RBC is 523% of Company Action Level ($2,731M total adjusted capital vs $522M CAL) — very strong; excess capital ~$2.1B. Cash & equivalents $10.1B. SBC is modest at $206M (~5% of NI) — low dilution for a financial.

Free cash flow / capital generation. OCF $8,323M (2025) on tiny $162M capex; the headline OCF is inflated by insurance/working-capital float, so the durable distributable figure is the ~$2.5–3.5B/yr of holdco cash, equivalently framed as “~88% of adjusted operating earnings returned.”

Verdict. Elite economics that genuinely improve with scale in the segment that matters. The ~50%+ ROE is real (not a data artifact), the GAAP-to-adjusted gap is small and legitimate, cash generation exceeds GAAP earnings, the balance sheet is a fortress, and dilution is minimal. The one earnings-quality watch item is the rate/NII vintage rolling over — durable, but partly offsettable.

7. Capital Allocation

Capital allocation is, alongside the AWM moat, the strongest part of the AMP story — and the clearest evidence management thinks like owners.

The buyback machine. Shares outstanding fell 116.8M (2020) → 91.3M (2025), −22% in five years (~−26% from 2019). Buybacks (cash-flow statement): $2,030M (2021), $1,978M (2022), $2,127M (2023), $2,448M (2024), $2,907M (2025) — cumulatively ~$12B+ over 2021–25. The Jul-2023 $3.5B authorization was exhausted by Q2-2025; a new $4.5B authorization (Apr-2025) runs through Jun-30-2027. In Q1-26 management explicitly “took advantage of the decline in our PE multiple” to repurchase 1.6M shares. (Fact — 10-K; 8-Ks; Q1-26 call.) Buying back ~5% of shares/yr at ~11–13x earnings while ROE stays ~50% is mechanically accretive — this is the textbook high-ROE capital-return compounder.

The dividend. DPS grew $4.01 (2020) → $6.53 (2025), a ~10% CAGR, raised 8% in 2025 and a further 6% in Q1-26 — yet the payout is only ~16–17% of net income, leaving a long runway. Total capital return is ~$3.4B/yr, ~85–90% of adjusted operating earnings, the 15th consecutive year of returning capital at a “differentiated rate.” (Fact — proxy; 10-K.)

M&A discipline. The one material deal (BMO EMEA, ~$845M, 2021) reinforced the weakest segment; otherwise growth is organic plus small bolt-on/reinsurance (cash-flow “acquisitions of subsidiaries” of $427M/$1,125M/$1,431M in 2023–25 are largely reinsurance/block transactions, not transformative M&A). AMP has not chased dilutive equity-funded deals at high multiples — capital goes to buybacks instead. Positive.

The June-2026 debt raise. An 8-K (filed 2026-06-09; priced 2026-06-04) issued $300M 4.800% senior notes due 2031 + $450M 5.350% notes due 2036 (~$742.5M net, off the Feb-2024 shelf), most likely to refinance the $500M 2.875% notes maturing September-2026. (Fact — 8-K + 424B5.) Routine terming-out at a modest rate step-up; recourse debt stays ~$3.1–3.3B; net debt remains negative. Not balance-sheet stress, not new leverage for buybacks — disciplined refinancing.

Incentive alignment — genuinely strong (a rarity for a large financial). The 2026 proxy’s Annual Incentive scorecard is Financial 70% (Net Revenues 15%, Earnings 25%, Adjusted Operating EPS 20%, Return on Equity-ex-AOCI 20%, Balance Sheet 20%) + Strategic 30%; ROE-ex-AOCI scored 5.0 “Distinguished” in 2025. Long-term PSUs are earned on EPS growth + average ROE + a relative-TSR modifier (0–150% with ±25pp TSR overlay). CEO Cracchiolo’s FY2025 total comp was ~$30.8M; CFO Berman ~$9.4M; say-on-pay support ~89%. (Fact — 2026 DEF 14A.) Tying ~40% of variable pay to ROE and the rest to per-share metrics — with relative-TSR discipline — is materially better aligned than the absolute-revenue/AUM frameworks most banks and asset managers use.

The governance demerit. Cracchiolo is long-tenured Chairman + CEO (CEO since the 2005 spinoff, ~21 years; combined roles) with no publicly named successor, and 2026 brought senior-officer retirements (CIO Davies 6/30/26; AWM’s Sweeney 4/3/26) that thin the bench. Pay quantum is high but performance (53% ROE, record EPS) supports it; the concentration/succession issue is the real flaw.

The insider read. Across a 51-filing sample spanning the 306-Form-4 corpus (2021–2026), there are zero code-P open-market purchases by any insider — only grants (A), tax-withholding (F), option exercises (M), sales (S), and gifts (G). The standard mega-cap-financial pattern: executives are paid heavily in equity and net-sell; no conviction buying at the current price. Mild negative / neutral — it does not contradict the quality thesis (large held balances and ownership guidelines exist), but there is no insider table-pounding.

Verdict. An intelligent, shareholder-aligned capital allocator: relentless accretive buybacks, a fast-growing well-covered dividend, M&A discipline, a fortress balance sheet, and a genuinely ROE/per-share-aligned comp structure. The blemishes are governance (combined Chair/CEO, no named successor) and the absence of insider conviction buying — neither thesis-breaking.

8. Changes and Headwinds — Last Two Years

AFIG channel build / partner churn (the biggest strategic change). Q1-26 signed Huntington Bank (~260 advisors, ~$28B, 10-yr deal, conversion Q4-26) as a takeaway after a >1-year competitive process, while losing Comerica (early-terminated after Fifth Third’s acquisition; $25M one-time make-whole; ~$18B leaving, conversion ~end-Q3-26). (Fact — Q1-26 call.) Net of the two, AMP adds ~$10B+ and 260 advisors — structurally strengthening (AFIG is a validated, growing outsourced-wealth channel) but exposing the channel’s weakness: bank partners get acquired and walk, making AFIG inherently lumpier and lower-switching-cost than the core channels. Net: mild positive with a 2026 flow air-pocket.

RPS de-risking (multi-year, ongoing). No new VA living benefits sold since mid-2022; rider mix down to 46%; LTC ~50% ceded to Genworth, fixed annuities ~89% ceded; RiverSource RBC 523%. (Fact — 10-K.) This strengthens the thesis — AMP is systematically shrinking the insurance tail risk that scares investors about owning a fee-based wealth manager with a legacy annuity book, converting RPS into a de-risked ~$800M/yr cash spigot. (New, modest residual: reinsurer credit exposure.)

Capital structure / buyback continuity. The June-2026 $750M refinancing (above); the Apr-2025 $4.5B buyback authorization; the 6% Q1-26 dividend raise. All strengthen the capital-return continuity.

Regulatory — SEC off-channel-communications settlement (resolved). August-2024: AMP among 26 firms settling SEC recordkeeping charges over unapproved messaging apps; AMP paid $50M (censure + remediation). One-time, industry-wide, ~1.4% of one year’s NI — a governance/compliance demerit, not thesis-changing; this was the “regulatory matter” behind part of the 2023 GAAP dip.

Regulatory/litigation — cash-sweep class actions (AMP is a named defendant). In Nov-2024 AMP was hit with putative class actions (Mehlman & Hultman v. Ameriprise, D. Minn.; Frey/Bender) alleging it paid 0.0–0.3% on uninvested sweep cash while earning large NII, breaching fiduciary duty and Reg BI; plaintiffs claim >$2B in lost client interest. The 8/19/2025 ruling (Judge Tunheim) granted AMP’s motion to compel arbitration on advisory accounts and granted-in-part/denied-in-part the motion to dismiss (part of the brokerage-account fiduciary theory survived). (Fact — D. Minn. docket; AdvisorHub/Financial Planning.) This modestly weakens the thesis but is a real-yet-contained tail risk: arbitration shrinks the class; AMP’s sweep is far smaller (~$29.4B, ~$6K avg balance) and a smaller share of earnings than at Schwab/MS; and the 10-K contingencies note treats litigation as ordinary-course (no specific material reserve broken out). AMP is the least cash-cow-dependent of the cohort, so even an adverse outcome hits a smaller earnings base.

Leadership / governance. 2026 senior-officer retirements (CIO Davies, AWM’s Sweeney); Cracchiolo remains Chair+CEO with no named successor. Weakens at the margin — orderly retirements that nonetheless thin the bench amid an unaddressed CEO-succession question.

Verdict. Net mildly strengthens, with two new overhangs. Strengtheners: AFIG validation (Huntington > Comerica net), continued RPS de-risking, disciplined refinancing, sustained buyback/dividend growth. Weakeners: AMP is now confirmed a named cash-sweep defendant (contained but real), and CEO/senior-officer succession is unaddressed. The strategic direction — organic, de-risked, capital-returning, channel-expanding — is reinforced.

9. Risk Analysis

The dominant risks are cyclical/beta risks stacked on a structurally good franchise — not idiosyncratic-blowup risks (no leverage cliff, no credit cliff, no going-concern issue) — plus two structural/governance overhangs (the recruiting war and succession). The asymmetry: limited downside protection if the market/rate cycle turns (earnings are near a cyclical high), offset by a fortress balance sheet and a relentless buyback that cushions per-share results.

Catastrophic-loss / total-loss assessment. The risk of a permanent total loss is low: no recourse-debt cliff, negative net debt, RBC 523%, modest SBC, and a fee-based revenue model. The realistic downside scenario is a cyclical earnings/multiple drawdown (rates + equities down together) of the order of 30–40%, not impairment — which is precisely why the entry price matters more than the thesis here.

10. Valuation Discussion (Embedded Expectations)

Use P/E, not EV/EBITDA. Enterprise value is meaningless for AMP (and for MS/SCHW/RJF/SF/BLK) because aggregators net ~$40B+ of client/bank cash, producing absurd negative/near-zero EVs and 75–260x EV/EBITDA. The right lenses are P/E, P/adjusted-operating-EPS, ROE, and total capital-return yield.

The peer comp table — the spine of the thesis.

* AMP GAAP ROE on real common equity ~54%; ROIC.ai’s “13.6%” is a data artifact (separate-account inclusion) and is excluded.

The central mispricing. AMP earns the highest operating ROE in the cohort yet trades at the second-lowest P/E (above only the distressed active manager TROW). The wealth pure-plays it most resembles in earnings mix (~65% AWM) trade at large premiums: LPLA ~26.7x, SCHW ~18.6x, MS ~14.7x, RJF ~13.4x, SF ~13.5x. AMP is ~3–7 turns below the brokerage/wealth median (~14–15x) and ~12–15 turns below the wealth pure-plays. The market is valuing a capital-light, ~53%-ROE wealth manager as if it were a slow, rate-levered diversified-financial/insurer — i.e., it weights the 16%-of-earnings annuity tail and the cyclical cash-sweep NII far more heavily than the 65% advice-fee engine. On AMP’s own history, the AZI valuation index puts it at the 40th percentile on P/E (composite 54th) — slightly cheap versus its own multi-year range, not a richest-ever name.

Embedded-expectations / reverse-DCF. At ~10.6x FY26E adjusted operating EPS (~$44) with ~53% ROE, a ~16% cash payout but ~88% total distribution (buybacks retiring ~3–4% of shares/yr), a justified-multiple frame (P/E = payout × (1+g) / (r−g)) at r=10% cost of equity is consistent with the market pricing only ~2–4% sustainable EPS growth — i.e., near-zero organic growth plus buyback accretion, with no re-rating credit. Equivalently, the market underwrites that current ~$44 EPS is at/near a cyclical peak (rate-driven sweep NII, −11% YoY) and that Columbia Threadneedle keeps bleeding, so it caps the multiple at an insurer/active-AM level.

What is priced correctly: NII/cash-spread compression is real and underway; Columbia is a structurally challenged active manager deserving a 10–16x sleeve; market beta (~1.05) means a chunk of EPS rides equity levels. What is priced incorrectly (the variant): the ~65% AWM advice/wrap engine is recurring, asset-sticky, growing organically, and structurally less rate-dependent than a blanket insurer multiple implies — the fee core that peers earn 18–27x for gets no credit.

Scenario analysis (FY28E adjusted operating EPS × fair P/E band — a directional value zone, not a target).

Even the bear EPS (~$42–45, roughly flat to FY26) at a trough ~9–11x lands a zone (~$380–495) that brackets today’s $467 — the stock already prices a bearish flat-EPS / no-re-rate outcome. The base case implies meaningful upside without any heroic re-rating; a partial re-rate toward wealth-peer multiples is incremental optionality on top.

Sum-of-the-parts (illustrative; allocate ~$44 FY26E adj-op-EPS by segment, apply segment-appropriate P/E).

• AWM (~$28.5 EPS-equiv) at ~16x (a discount to LPLA 27x / SCHW 19x, a premium to MS/RJF for higher ROE) = ~$456/sh
• Asset Management (~$8.5 EPS-equiv) at ~10x (TROW/BEN active-AM level) = ~$85/sh
• RPS (~$7.0 EPS-equiv) at ~8x (runoff/insurer multiple) = ~$56/sh
• SOTP ≈ ~$597/sh vs $467 spot → ~28% above the market price.

The SOTP confirms the comp-table read: the consolidated ~11.6x multiple applies the insurance/active-AM discount to the whole company, including the AWM wealth core that on its own — at a still-discounted wealth multiple — is worth roughly today’s entire share price. Even valuing AWM at MS/RJF’s ~14–15x (not LPLA’s 27x) leaves SOTP above spot. (No price target; no recommendation — these are scenario bands.)

11. Variant Perception

Consensus belief. AMP is a well-run but cyclically-peaked financial whose earnings were inflated by the 2023–24 high-rate cash-sweep windfall; as the Fed cuts, NII rolls over, and the active-AM drag plus equity-market beta cap the story. “Quality but ex-growth; a buyback-flattered EPS machine; correctly classified near a diversified-financial/insurer ~11–12x.” The flat-to-down 12-month tape (rs_12m −6.5%, ~17% off peak) reflects this.

Strongest bull case. AMP is fundamentally a ~53%-ROE, capital-light wealth manager (65% of earnings, recurring advice/wrap fees, sticky AUM, organic flows + advisor productivity) wearing an insurer’s clothing and an insurer’s multiple. As the legacy annuity/protection tail (RPS, 16%) runs off and the fee/advice mix keeps rising, the classification discount should compress and the stock should re-rate toward wealth peers (RJF/MS ~14–15x at minimum; LPLA/SCHW 18–27x at the bull end). Combine modest EPS growth + ~3–4%/yr share shrink + a 3–4-turn re-rate and the total return is large with little fundamental heroism. Falsification: if NII keeps falling and AWM net flows decelerate to peer-lagging levels for several quarters, the “it’s really a wealth comp” thesis breaks — the re-rate never comes because the fee engine isn’t actually outgrowing.

Strongest bear case. Today’s EPS is a rate-cycle peak; cash-sweep NII ($1,956M, −11%) keeps compressing as cuts continue, and a chunk of fee income is pure equity-market beta (~1.05) that reverses in a drawdown. The headline “11x P/E” is buyback-flattered — ~88% of earnings goes to distributions, masking thin organic growth — and Columbia Threadneedle is in secular active-outflow decline. The market’s insurer/diversified-financial classification is correct, not a mistake, because the company carries real annuity/insurance liability tails and rate sensitivity that LPLA/SCHW don’t. Falsification: if sweep NII stabilizes (a shallower rate path) and adjusted operating EPS grows through a Fed-cut cycle (proving AWM offsets NII), the “peak earnings” core of the bear collapses.

The 3–5 assumptions that matter most. (1) The trajectory of cash-sweep NII as rates fall — the single biggest near-term EPS swing factor. (2) AWM net flows + advisor productivity — does the fee engine grow organically through the rate cycle? (3) Whether the market re-rates toward wealth peers or keeps the insurer discount — the classification debate, where most of the upside lives. (4) Columbia Threadneedle’s outflow/fee trajectory (the 19% drag). (5) Equity-market level (the fee-on-AUM beta).

Factor-positioning read (the tape as evidence). Market beta ~1.05 (dominant loading, R² 0.57–0.71); style factors largely zeroed except a slight Value tilt (+0.03) and negative Growth (−0.34) in the all-factors model. Leaderboard: y1 return −6.5% (max drawdown −20.9%), y3 +15%/yr, y5 +14.6%/yr; rs_12m −6.5%, rs_peak −17.1%; a nascent m3 bounce (~+6.9% raw quarter). This profile — pure market beta, slight value tilt, no momentum, lagging the market for a year, ~17% off the high — describes an abandoned-quality / relative-laggard name the market has de-rated and stopped watching, not a crowded momentum trade and not a falling knife. It is evidence consensus may be offsides (cheap, ignored, high-ROE) rather than a name being correctly punished for deterioration — with the caveat that beta ~1.05 means it falls in a broad equity drawdown regardless of the fundamental thesis.

12. Fact vs. Interpretation Table

13. Open Questions

1. The precise FY26–28 cash-sweep NII trajectory under the actual Fed path — the single biggest EPS swing factor, modeled here as a scenario range rather than a point estimate.
2. Does AWM net new flow + advisor productivity demonstrably grow adjusted operating EPS through a cut cycle? 2025 proved it can with markets up (+14% fees vs −11% NII); the unproven scenario is rates down + markets down together. Needs 2–3 more quarters.
3. The magnitude of the 2026 AWM net-flow “air-pocket” between Comerica outflows (Q2–Q3, ~$18B) and Huntington inflows (Q4, ~$28B) — management declined to quantify by quarter.
4. CEO succession timeline — no named successor; the board’s succession process is not publicly disclosed. Material to the key-person risk weighting.
5. Quantified reserve (if any) for the cash-sweep class actions — the 10-K contingencies note is generic; the surviving brokerage-fiduciary theory’s exposure range is undisclosed.
6. Columbia Threadneedle’s terminal trajectory — at what AUM/flow level does the active-AM melt threaten the 35–39% target margin, and is a divestiture/sale ever on the table?

14. What Must Be True

For the bull (re-rating + durable compounding):

• AWM advice-fee growth must keep outrunning NII compression through the Fed-cut cycle (high-single-digit-plus AWM earnings growth with NII falling), proving the fee engine — not the rate vintage — drives the franchise.
• AWM organic net flows must stay competitive (~4–5%+ of beginning assets) despite the LPL/RJF recruiting war — the moat must hold on per-advisor economics.
• The market must begin re-rating the multiple toward wealth peers (even RJF/MS ~14–15x) as the annuity tail shrinks and the fee mix rises.
• Falsification test: two-to-three consecutive quarters in which NII compresses faster than fees grow and AWM net flows decelerate to peer-lagging levels — the “wealth comp” thesis is wrong, and the insurer multiple is deserved.

For the bear (peak earnings + deserved discount):

• Cash-sweep NII must keep compressing materially on continued cuts, and the equity-market beta must reverse a chunk of fee AUM, pulling adjusted operating EPS down from the ~$39–44 vintage.
• Columbia Threadneedle’s active-outflow decline must continue (or worsen), validating the active-AM multiple cap.
• The market must be right that AMP’s annuity/insurance tail and rate sensitivity justify the diversified-financial classification — i.e., no re-rate.
• Falsification test: adjusted operating EPS grows through a full Fed-cut cycle while sweep NII stabilizes — the “peak earnings” core of the bear collapses, and the cheap multiple becomes indefensible.

The two falsification tests are mirror images and both turn on the same observable: does the AWM fee engine out-earn NII compression over the next several quarters? That is the highest-information variable in the entire thesis.

15. Source Appendix

Principal primary sources relied on:

• Ameriprise Financial FY2025 Form 10-K (filed 2026-02-19; EDGAR CIK 0000820027) — segment business descriptions, consolidated financial statements, MD&A segment tables, ROE-ex-AOCI reconciliation, capital/liquidity, AOCI, reinsurance, risk factors, market-risk sensitivities.
• Q1 2026 earnings call transcript (2026-04-23) — adjusted operating EPS $11.26, ROE >54%, AUM/A $1.7T, wrap $664B, ~$29.4B sweep, productivity $1.2M, Huntington/Comerica, AM outflows, capital return.
• 2026 DEF 14A (filed 2026-03-20) — incentive scorecard, PSU design, executive compensation, say-on-pay.
• 8-Ks — $750M June-2026 senior-notes issuance; senior-officer retirements; $4.5B buyback authorization; quarterly earnings.
• Cash-sweep litigation — Mehlman & Hultman v. Ameriprise (D. Minn. No. 0:24-cv-03018), 8/19/2025 Memorandum Opinion; AdvisorHub; Financial Planning.
• SEC off-channel-communications settlement (Aug-2024) — SEC press release; trade press.
• ROIC.ai — income statement, profitability ratios, valuation multiples for AMP and peers (LPLA, SCHW, MS, RJF, SF, BLK, TROW, BEN); enterprise-value flagged unusable for the cohort.
• AZI — five-year daily price CSV (event map) and valuation-index own-history percentiles (composite 54th, P/E 40th).
• FactorsToday — loadings, leaderboard, stock-info (beta ~1.05, factor profile, relative strength).
• Industry data — Morningstar/McKinsey 2025 asset-management trends; InvestmentNews/Financial Planning advisor-recruiting data.

This report contains no buy/sell recommendation and no price target outside the clearly-labeled “Claude’s Take” block. Facts are cited to primary sources; interpretations and assumptions are labeled as such. Management commentary is treated as hypothesis validated against filings and external evidence.

APPENDIX A — Standard Diligence Questionnaire

Supplemental to the research memo. Report date 2026-06-21. Answers grounded in the research log; Fact / Interpretation / Assumption labeled where it matters. Where a question does not map to a wealth-management/insurance hybrid, the correct sector analog is given.

General

What thoughtful questions have other investors asked about this company? The recurring institutional debates: (1) Is AMP “really” a wealth manager or a rate-levered diversified financial? — the classification that drives the multiple. (2) How much of the record ~53% ROE / ~$39 EPS is a high-rate cash-sweep vintage that reverses on Fed cuts? (3) Can AWM advice-fee growth keep outrunning NII compression through a cut cycle? (4) Is the cheap multiple a value opportunity or a correct discount for the annuity tail + active-AM melt + equity beta? (5) What is the CEO-succession plan after 21 years of Cracchiolo? (6) How exposed is AMP to the cash-sweep litigation wave vs Schwab/Morgan Stanley? (Interpretation, synthesized from the call Q&A and peer coverage.)

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? A high (Interpretation). Record adjusted operating EPS ($39.29) and ~53% ROE rest on both a high-rate cash-sweep NII vintage (AWM NII already −11% in 2025 and compressing) and a bull-market AUM peak ($1.7T AUM/A, wrap +17% mostly on market beta). A simultaneous rate-cut-plus-equity-drawdown would compress fees and spread together.

Driven by the external environment or internal actions? Both. Internal: the deliberate shift to fee-based advice, relentless buyback (shares −22% in 5yr), RPS de-risking, productivity gains ($1.2M/advisor). External: the rate cycle (sweep NII) and equity-market levels (fee-on-AUM). The durable internal actions are why earnings held up even as NII rolled over.

How stable are revenues? ~60% of revenue is recurring management/advice fees on AUM — stable but market-linked. The rate-sensitive NII leg (~19% of revenue) is the swing factor. Through-cycle, AMP grew revenue every year 2020–25 ($11.9B → $18.48B). (Fact.)

Outlook for products/services? Wealth advice is a secular grower; the active-AM product set (Columbia) is in structural decline (mitigated by ETF/SMA/alts pivot); RPS is a deliberate managed runoff. (Interpretation.)

How big will this market be? US wealth/advice is a large, growing, domestic-led market (boomer decumulation + next-gen accumulation), with EMEA/Asia asset-management exposure via Columbia Threadneedle. AMP targets the mass-affluent ($500K–$5M) plus HNW. (Fact/Interpretation.)

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Wealth/advice: more competitive for advisor talent (inflating LPL/RJF recruiting war) but structurally favorable for asset gatherers. Active AM: brutally competitive and consolidating. (Interpretation.)

How profitable is the business (ROIC, ROE)? Elite. Adjusted operating ROE-ex-AOCI 53.2%; GAAP ROE on real common equity ~54%. (Note: ROIC.ai’s “13.6% ROE” is a data artifact from separate-account inclusion — ignore it.) Returns far exceed cost of capital. (Fact.)

How profitable is the industry — competitors, barriers to entry? Wealth/advice earns high, recurring fee-on-AUM margins with real barriers (client switching costs, advisor relationships, platform scale, regulatory licensing). Active AM earns compressing fees with low barriers against passive. (Interpretation.)

Can the business be easily understood? Mostly — a fee-gathering wealth manager with a bank spread leg and a runoff insurance book. The complications are the GAAP-vs-adjusted insurance marks and the AOCI/thin-equity ROE optics. (Interpretation.)

Can it be undermined by foreign low-cost labor? No — advice is relationship- and regulation-bound and domestic. The relevant disruption vector is technology/AI + fee transparency on the cash-sweep spread, not offshoring. (Interpretation.)

Do brands matter? Moderately. The Ameriprise/Columbia Threadneedle/RiverSource brands matter, but the advisor owns much of the client relationship — the brand supports retention, it is not the primary moat. (Interpretation.)

Nature of competition / customers’ switching costs? Competition is on advisor productivity/economics, platform/tech, and client experience (AMP wins on per-advisor economics, not headcount). Client switching costs are real (multi-product relationships, tax/transfer friction, advisor loyalty) but advisor switching costs are lower (advisors are recruitable). (Interpretation.)

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The AWM franchise value (advisor force, client relationships, productivity) is largely unrecognized; conversely, ~$140B+ of separate-account/policyholder assets are on the balance sheet but are not common equity (the source of the ROIC.ai ROE error). (Interpretation.)

Off-balance-sheet liabilities? Reinsured legacy blocks (LTC ~50% ceded to Genworth; fixed annuities ~89% ceded) leave RiverSource primarily liable as direct insurer — a residual reinsurer-credit exposure. Off-balance-sheet client sweep (~$5.1B) and third-party cash (~$48B) are placement relationships, not liabilities. (Fact/Interpretation.)

How conservative is the accounting? Reasonably. The adjusted-operating measure backs out non-cash insurance marks (legitimate, not flattering); OCF/NI 2.34x corroborates real cash earnings; SBC is modest. The deliberate de-risking of the VA book reduces actuarial-assumption risk. (Interpretation.)

How CapEx-hungry? Very light — capex ~$162M on $18.5B revenue; the business is human-capital and technology-intensive, not physical-asset-intensive. (Fact.)

Capital Allocation & Management

How much FCF does the business generate, and how is it used? Headline OCF ~$8.3B is float-inflated; the durable holdco-distributable figure is ~$2.5–3.5B/yr. Capital is returned at ~85–90% of adjusted operating earnings (~$3.4B in 2025, 15th straight year), split buybacks-heavy plus a growing dividend. (Fact.)

Significant acquisitions recently? No transformative M&A; the one material deal (BMO EMEA AM, 2021, ~$845M) reinforced the weakest segment. Recent “acquisitions of subsidiaries” line items are largely reinsurance/block transactions. Discipline is a positive. (Fact/Interpretation.)

Buying back shares? Yes, relentlessly — shares −22% in 5yr (~$12B+ repurchased 2021–25); new $4.5B authorization through Jun-2027; management leaned in on the 2026 multiple dip. (Fact.)

Issuing large amounts of new shares to insiders? No — SBC is modest (~$206M, ~5% of NI); net dilution is minimal. (Fact.)

Compensation policy of directors/management? Genuinely shareholder-aligned: annual scorecard weights ROE-ex-AOCI 20% + adj op EPS 20% + earnings 25% + revenue 15%; PSUs on EPS growth + average ROE + relative-TSR. CEO ~$30.8M, CFO ~$9.4M; say-on-pay ~89%. (Fact.) Demerit: combined Chair/CEO, no named successor.

Motivations of management? Per-share value creation and capital-return discipline are deeply embedded (“built not bought,” 15 years of differentiated return, multiple comp metrics aligned). The risk is key-person concentration in Cracchiolo. (Interpretation.)

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? No — a US C-corporation common stock (NYSE: AMP), standard 1099 dividends. (Fact.)

Dividend policy? Quarterly cash dividend, DPS $4.01 (2020) → $6.53 (2025), ~10% CAGR, raised 8% in 2025 and 6% in Q1-26; payout only ~16–17% of NI (long runway). Trailing yield ~1.4%. The primary return vehicle is buybacks, not the dividend. (Fact.)

How profitable is the business? Among the most profitable large financials in the US: ~53% adjusted operating ROE, ~27% adjusted operating margin, ~30% AWM segment margin. (Fact.)

Is net income diverging from cash from operations? OCF exceeds NI (2.34x in 2025) due to insurance/working-capital float — cash generation is stronger than GAAP NI, a positive divergence. Distributable cash is the ~$2.5–3.5B holdco figure, not the float-inflated OCF. (Fact/Interpretation.)

Risks & Downside

What factors would cause the stock to decline? (1) A simultaneous Fed-cut + equity-drawdown compressing both NII and fee AUM; (2) NII compressing faster than fees grow; (3) AWM net-flow deceleration / advisor attrition in the recruiting war; (4) an adverse cash-sweep litigation outcome forcing higher sweep payouts; (5) a disorderly CEO succession; (6) accelerating Columbia Threadneedle outflows. (Interpretation, from the risk matrix.)

Risk of a catastrophic loss? Low. No recourse-debt cliff, negative net debt, RiverSource RBC 523%, modest SBC, fee-based revenue model. The realistic downside is a cyclical ~30–40% earnings/multiple drawdown, not impairment. (Interpretation.)

Chance of a total loss? Remote — a diversified, profitable, well-capitalized franchise with a fortress balance sheet. (Interpretation.)

Recent News & Events

Has the business environment changed recently? Yes, at the margin: the rate cycle is turning (NII compression), the advisor-recruiting war is intensifying, and the cash-sweep litigation/transparency wave is live. AMP itself signed Huntington (AFIG) and lost Comerica. (Fact.)

Significant acquisitions? None recently of scale; Huntington is a 10-year channel win (~$28B), not an acquisition. (Fact.)

Change in accounting policies? No material change; the long-duration-insurance (LDTI) framework drives the non-cash VA marks that the adjusted measure backs out. (Fact.)

Recent changes — new markets, facilities, management? AFIG bank/credit-union channel expansion (Huntington); Signature Wealth UMA launch; 2026 senior-officer retirements (CIO Davies, AWM’s Sweeney); $750M June-2026 senior-notes refinancing; new $4.5B buyback authorization. (Fact.)

APPENDIX B — Source Appendix

Report date 2026-06-21. Primary sources prioritized. Facts cite the underlying filing/data; interpretations are labeled in the memo. All URLs accessed 2026-06-21 unless noted.

Primary — SEC filings (EDGAR CIK 0000820027)

Primary — Earnings call

Litigation & regulatory (public)

• Mehlman & Hultman v. Ameriprise Financial, D. Minn. No. 0:24-cv-03018 — Memorandum Opinion & Order (Judge John R. Tunheim), 8/19/2025 (compelled arbitration on advisory accounts; partial survival of brokerage-fiduciary theory). Also Frey / Bender suits (>$2B claimed). Sources: law.justia.com; AdvisorHub; Financial Planning; classaction.org; topclassactions.com.
• SEC off-channel-communications settlement, Aug-2024 — AMP $50M (of ~$393M / 26 firms). SEC press release; Compliance Week; Star Tribune.

Quantitative data services

• ROIC.ai MCP — income statement, balance sheet, cash flow, profitability ratios (ROE/ROIC/margins), valuation multiples (P/E, P/B, P/S) for AMP and peers (LPLA, SCHW, MS, RJF, SF, BLK, TROW, BEN); enterprise-value flagged unusable for the brokerage/wealth cohort (client-cash distortion). Third-party aggregated; reconciled to filings. (Note: ROIC’s AMP ROE/P/B are data artifacts — excluded.)
• AZI — five-year daily adjusted-close price CSV (event map: 5yr low ~$210.6 14-Jul-2022, ATH ~$564.1 29-Jan-2025, $467.43 18-Jun-2026, 52wk ~$428.8–$542); valuation-index own-history percentiles (composite 54th, P/E 40th, P/B 67th, P/S 56th).
• FactorsToday — stock-loadings (market beta ~1.05–1.10, Growth −0.34, Value +0.03, R² 0.57–0.71), leaderboard (y1 −6.5%/MDD −20.9%, y3 +15%, y5 +14.6%), stock-info (rs_12m −6.5%, rs_peak −17.1%), related-stocks (MS, RJF, SF).

Industry & trade data (public)

• Morningstar / McKinsey 2025 asset-management trends — active-MF outflows ~$640B (2025), ~$4T cumulative; passive AUM ~$19.1T > active ~$16.2T; fee compression; active ETFs ~$1.2T cumulative inflows.
• InvestmentNews / Financial Planning 2025 — advisor recruiting (LPL ~32,000 advisors +601, RJF record headcount +313, LPL/Commonwealth ~77.5% retention).